ARCHIVES

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

December 25, 2009

Special Report: KRAS Finding Changes Oncology Practice But Poses Profound Regulatory Dilemma

January 30, 2009

Obama Calls for Bigger Investment in Science, GOP Plans Cuts

January 28, 2011

DCT Board Okays Recompetitions

June 21, 1985

IL13-PE38 Looks Promising In Early Tests Against Gioma

September 27, 2002

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003